Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pediatric neurology · Developmental and Epileptic Encephalopathy 85 With or Without Midline Brain Defects

Ongoing Care, Monitoring, and Quality of Life

At a Glance

Long-term DEE85 care combines seizure management with monitoring of growth, heart health, breathing, feeding, and development. Physical, occupational, speech, communication, nutrition, and supportive care can improve comfort, participation, meaningful progress, and family quality of life.

While the initial focus of a Developmental and Epileptic Encephalopathy 85 (DEE85) diagnosis is often on seizure control, the long-term journey involves a broader view of your child’s health and happiness. Because this condition is caused by a variant in the SMC1A gene, it can affect multiple systems in the body, requiring a coordinated “multidisciplinary” team of specialists to provide holistic care [1][2].

Managing Non-Neurological Health

Children with DEE85 require careful monitoring of more than just brain activity. Research has identified several key areas that need ongoing attention:

  • Cardiac Health: Approximately 20% of children in a large international study of DEE85 were found to have cardiovascular (heart) malformations [3]. A baseline evaluation by a pediatric cardiologist, which may include an echocardiogram (an ultrasound of the heart), may be discussed depending on the child’s presentation, examination, and local guidance [3].
  • Respiratory Care: Difficulties with breathing (respiratory compromise) were reported in over half of infants in the neonatal period within the same study [3]. This neonatal finding does not automatically mean every child has a lifelong respiratory disorder. However, ongoing monitoring for apnea (pauses in breathing) or issues with swallowing that could lead to lung infections (aspiration) is a vital part of long-term care based on symptoms.
  • Growth Monitoring: Doctors will track your child’s “serial growth,” with a particular focus on head circumference. In DEE85, head growth often slows down after birth (postnatal microcephaly), even if it was normal at birth [3].
  • General Health: Routine care domains relevant in severe developmental epilepsy include sleep, reflux, constipation, vision, hearing, and bone health/orthopedics.

Building Your Therapy Team

Because DEE85 is associated with global developmental delay, early and consistent therapy is the cornerstone of supporting your child’s potential [4]. Your team will likely include:

  1. Physical Therapy (PT): Focuses on gross motor skills, such as sitting, standing, or walking. PTs also help prevent “contractures” (stiffening of the muscles) and recommend equipment like braces or specialized seating [3][5].
  2. Occupational Therapy (OT): Helps with fine motor skills, like grasping objects, and addresses “sensory needs”—how your child processes sights, sounds, and touch [5].
  3. Speech-Language Pathology (SLP) & AAC: While speech may be limited, communication is still possible. Augmentative and Alternative Communication (AAC)—which can range from simple picture boards to high-tech eye-gaze devices—helps children express their needs and emotions [5][6].
  4. Feeding and Nutrition: Specialized support may be needed to ensure your child can eat safely without choking and is getting enough calories for growth [5].

Quality of Life and Supportive Care

The goal of care in DEE85 is to maximize comfort and participation in family life. This is where palliative care (or supportive care) can be invaluable. This specialty is not just for the end of life; rather, it focuses on managing complex symptoms, reducing the burden of too many medical appointments, and supporting the mental health of the entire family [1][7].

Understanding the Long-Term Path

Parents often ask about the “prognosis” or what the future holds. In the largest study of DEE85 to date, most children experienced significant developmental challenges and drug-resistant seizures [3]. However, “prognosis” is not a fixed number or a guaranteed outcome.

  • Survival: Long-term outcome and survival data are currently limited, and life expectancy is not reliably known. Discuss individualized risks, such as epilepsy-related safety and Sudden Unexpected Death in Epilepsy (SUDEP), directly with your neurologist.
  • Variability: Your child’s specific variant, their response to seizure medications, and the presence of any other health issues (like heart defects) all play a role in their individual journey [8][9].

The focus of ongoing care is often on “meaningful milestones”—the small, vital gains in communication, movement, and comfort that improve your child’s daily life and your family’s experience together [5].

Common questions in this guide

What health checks should my child with DEE85 have over time?
Ongoing care may include tracking growth and head circumference, reviewing seizures and development, and checking symptoms involving breathing, swallowing, sleep, vision, hearing, reflux, constipation, and bone health. A pediatric cardiology evaluation, potentially including an echocardiogram, may be considered based on the child’s findings and local guidance.
Which therapies can support development in DEE85?
Physical therapy can support movement and help prevent contractures, while occupational therapy addresses fine-motor and sensory needs. Speech-language therapy, augmentative and alternative communication, and feeding or nutrition support can improve communication, safe eating, and growth.
What is AAC, and how can it help a child with DEE85?
Augmentative and alternative communication is a way to communicate without relying only on spoken speech, using tools such as picture boards or eye-gaze devices. A speech-language professional can help choose and practice a system so your child can express needs, choices, and emotions.
Does breathing trouble in infancy mean my child will have lifelong respiratory problems?
Not necessarily; breathing problems reported during the newborn period do not automatically predict a lifelong respiratory disorder. Families should discuss monitoring for pauses in breathing, swallowing problems, or signs of aspiration with the child’s care team.
What can we expect for my child’s long-term outlook with DEE85?
DEE85 varies from child to child, and many children have substantial developmental challenges and seizures that are difficult to control. Long-term survival and life-expectancy data are limited, so the child’s genetic variant, seizure response, and other health problems should be discussed with the neurologist, including epilepsy-related safety and sudden unexpected death in epilepsy risk.
How can palliative care help a child with DEE85?
Pediatric palliative care can be involved alongside disease-directed treatment and is not limited to end-of-life care. It can help manage complex symptoms, coordinate appointments, and support the child’s comfort and the family’s emotional health and quality-of-life goals.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on developmental and epileptic encephalopathy, 85, with or without midline brain defects.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given the clinical findings in DEE85 cohorts, should my child have a baseline evaluation with a pediatric cardiologist?
  2. 2.What specific symptoms of swallowing difficulties, aspiration, or sleep apnea should prompt us to see a pulmonologist or feeding specialist?
  3. 3.How can we integrate Augmentative and Alternative Communication (AAC) into my child's daily routine to support their ability to express needs?
  4. 4.Are there specific bone health or orthopedic issues (like scoliosis) that we should monitor for as my child grows?
  5. 5.Can you refer us to a pediatric palliative care team to help coordinate symptom management and support our family's quality-of-life goals?

References

References (9)
  1. 1

    Beyond seizures: proceedings of the ERN EpiCARE working group 18 on developmental and epileptic encephalopathies.

    De Giorgis V, Dalla Bernardina B, Brambilla I, et al.

    Epilepsy & behavior : E&B 2026; (182()):111112 doi:10.1016/j.yebeh.2026.111112.

    PMID: 42161158
  2. 2

    The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives.

    Specchio N, Trivisano M, Aronica E, et al.

    The Lancet. Child & adolescent health 2024; (8(11)):821-834 doi:10.1016/S2352-4642(24)00196-2.

    PMID: 39419567
  3. 3

    SMC1A epilepsy syndrome: clinical data from a large international cohort.

    Gibellato E, Cianci P, Mariani M, et al.

    American journal of medical genetics. Part A 2024; (194(7)):e63577 doi:10.1002/ajmg.a.63577.

    PMID: 38421079
  4. 4

    Learnings in developmental and epileptic encephalopathies: what do we know?

    Perinelli MG, Riva A, Amadori E, et al.

    Expert review of neurotherapeutics 2023; (23(1)):45-57 doi:10.1080/14737175.2023.2176221.

    PMID: 36726225
  5. 5

    Caregiver-reported meaningful change in functional domains for individuals with developmental and epileptic encephalopathy: A convergent mixed-methods design.

    Downs J, Haywood S, Ludwig NN, et al.

    Developmental medicine and child neurology 2025; (67(12)):1616-1627 doi:10.1111/dmcn.16363.

    PMID: 40372822
  6. 6

    Survey of rehabilitation approaches and plans for individuals with dravet syndrome (RAPIDS) in Italy: Current practices and strategies to progress.

    Porto C, Perulli M, Arpaia C, et al.

    Epilepsy & behavior : E&B 2024; (157()):109888 doi:10.1016/j.yebeh.2024.109888.

    PMID: 38991471
  7. 7

    Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.

    Amin S, Møller RS, Aledo-Serrano A, et al.

    Epilepsia open 2024; (9(3)):832-849 doi:10.1002/epi4.12914.

    PMID: 38450883
  8. 8

    Phenotypes and Genotypes in Patients with SMC1A-Related Developmental and Epileptic Encephalopathy.

    Bozarth XL, Lopez J, Fang H, et al.

    Genes 2023; (14(4)) doi:10.3390/genes14040852.

    PMID: 37107610
  9. 9

    Linking Genotype to Clinical Features in SMC1A-Related Phenotypes: From Cornelia de Lange Syndrome to Developmental and Epileptic Encephalopathy, a Comprehensive Review.

    Astorino MF, Speranza D, Luppino G, et al.

    Genes 2025; (16(10)) doi:10.3390/genes16101196.

    PMID: 41153413

This page provides general educational information about ongoing care and quality of life in DEE85 and does not constitute medical advice. Your child’s neurologist and multidisciplinary care team can tailor monitoring and support to your child’s needs.